Patent 7407947 was granted and assigned to Novosom AG on August, 2008 by the United States Patent and Trademark Office.
An amphoteric compound based on a sterol skeleton, the 3-position of the sterol ring system being substituted by one or more amphoteric groups having an isoelectric point of between about 4 and 9, together with liposomes containing such compounds and their uses.